VJHemOnc is committed to improving our service to you

SOHO 2020 | Impact of COVID-19 on CAR T-cell therapies

VJHemOnc is committed to improving our service to you

David L. Porter

David L. Porter, MD, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, explores the impact of the COVID-19 pandemic on the treatment and management of patients with hematological malignancies currently recieving CAR T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter